Salute e Benessere

Coloplast A/S - Trading in Coloplast shares by board members, executives or…

Please see enclosed pdf. Attachment 03092024_trading_in_shares_NAN
Nasdaq GlobeNewswire
03/09/2024

MAYBELLINE NEW YORK BRINGS BACK ITS ICONIC 90's JINGLE "MAYBE IT'S MAYBELLINE"

"`Maybe It's Maybelline' is an iconic anthem that has defined beauty for generations, achieving an astounding 84% brand recall," said Trisha Ayyagari, Global Brand President for Maybelline New York. "Our jingle captures the essence of who we are as a brand, embodying self-confidence, authenticity, and empowerment. It has transcended pop culture conversations, decade after decade, and we are thrilled to reintroduce a fun and modernized version to a new generation of cultural…
PR Newswire
03/09/2024

Simtra BioPharma Solutions Appoints Dr. Mike Schäfers as Chief Commercial…

Dr. Schäfers brings extensive experience from leadership roles at LTS Lohmann Therapie-Systeme AG, Aenova Holding GmbH, and West Pharmaceutical Services. At LTS, Dr. Schäfers served as Chief Commercial Officer and managed a global team across Germany, the U.S., and China. Throughout his career, he has successfully developed strategies that significantly contributed to business growth, managed business collaborations as well as partnerships and led key acquisitions and integration activities...
Nasdaq GlobeNewswire
03/09/2024

Caristo Diagnostics Recognized as Quarterfinalist in the Digital Health Awards…

This recognition highlights the company's dedication in c­­­­­­­­­­­­­­­reating a new paradigm to prevent heart attacks and fight cardiac disease by uncovering hidden inflammation. The Digital Health Awards honor organizations making strides in improving healthcare efficiency, effectiveness and equity with their digital innovations. As a quarterfinalist, Caristo stands out for its commitment to applying advanced AI technology to cardiovascular disease diagnosis, supporting healthcare…
PR Newswire
03/09/2024

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational…

REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies. REC-994 met its primary endpoint of safety and tolerability, demonstrating a similar profile across placebo and both 200mg and 400mg dosage-arms with regard to the frequency and severity of adverse events after 12 months of treatment. Magnetic...
Nasdaq GlobeNewswire
03/09/2024

ViaLase to Present at the 42nd Congress of the European Society of Cataract and…

Presentations at ESCRS 2024 will provide insights into the company's ViaLase® Laser* and 3-year outcomes of the first-in-human study of femtosecond laser image-guided high-precision trabeculotomy (FLigHT) treatment in patients with glaucoma. ViaLase recently announced that it had received CE (Conformité Européenne) Mark approval in the European Union (EU) for its ViaLase Laser for the treatment of adult patients with primary open-angle glaucoma (POAG). The ViaLase Laser is the first and only…
PR Newswire
03/09/2024

ADC Therapeutics to Present at Upcoming Investor Conferences

H.C. Wainwright 26 thAnnual Global Investment ConferenceDate: September 9, 2024 Presentation Time: 7:00 a.m. ET Format: Virtual Fireside ChatSpeaker: Ameet Mallik, Chief Executive Officer 10 thCantor Global Healthcare Conference 2024Date: September 18, 2024Presentation Time: 11:30-12:00 p.m. ET Format: Fireside ChatSpeaker: Ameet Mallik, Chief Executive Officer Live webcasts of the presentations will be available via the Events & Presentations page in the Investors...
Nasdaq GlobeNewswire
03/09/2024

Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable…

The notes will be general unsecured obligations of the Issuer and will accrue interest payable semiannually in arrears. The Issuer's obligations under the notes will be fully and unconditionally guaranteed on a senior unsecured basis by Jazz Pharmaceuticals; will rank pari passu in right of payment with the Issuer's existing 2.000% exchangeable senior notes due 2026; will be effectively subordinated to the Issuer's guarantees of the indebtedness under Jazz Pharmaceuticals' credit agreement (the…
PR Newswire
03/09/2024

Bridge to Life Announces Three Oral/Mini-Oral Presentations on the use of HOPE…

Presentations include: Presentations include: September 23 : Liver techniques & malignancy (Mini-Oral Presentation,10:40 a.m.-12:10 p.m.TRT) Outcomes of redo-liver transplantation using hypothermic oxygenated machine perfusion: a multicentre cohort study (REDO-HOPE), ID #373, D. Patrono (General Surgery 2U - Liver Transplant Unit, AOU Città della Salute e della Scienza diTorino ), et al September 24 : Biomarkers and immune monitoring (Mini-Oral Presentation,10:40 a.m...
PR Newswire
03/09/2024

BVI to Launch New SERENITY and SERENITY Toric Premium Monofocal IOLs, Delivering…

Non-diffractive IOLs SERENITY and SERENITY Toric are the second generation of BVI's original, innovative ISOPURE premium monofocal IOL launched in 2019.These IOLs incorporate patented ISOFOCAL optic technology to provide both distance vision and intermediate vision. 1The ground-breaking double c-loop POD platform is specifically engineered to deliver precise astigmatism correction and stable IOL positioning. 2 These lenses are designed to meet the growing demand for...
Nasdaq GlobeNewswire
03/09/2024

Recor Medical Endorses European Society of Cardiology's New Guidelines for…

Hypertension, or high blood pressure, affects more than one billion people worldwide. It is known as the "silent killer" because many people do not know they have it and, over time, it can lead to serious health issues. About three-fourths of the patients who are treated for hypertension remain uncontrolled despite making healthy lifestyle changes and taking multiple medications. Recor's Paradise™ Ultrasound Renal Denervation (uRDN) system is a first-of-its-kind ultrasound-based...
PR Newswire
03/09/2024

Calliditas Therapeutics takes certain corporate actions following announcement…

In light of the above, and in accordance with a request from Asahi Kasei, the Board of Directors of Calliditas has resolved to apply for delisting of the Company's common shares (the "Common Shares") from Nasdaq Stockholm, as well as its American Depositary Shares ("ADSs") representing its Common Shares from the Nasdaq Global Select Market. In light of the above, and in accordance with a request from Asahi Kasei, the Board of Directors of Calliditas has resolved to apply for…
PR Newswire
03/09/2024

AliveDx Receives IVDR-CE Mark for Multiplexed Assay to Accurately Detect Celiac…

Celiac disease is a chronic autoimmune disorder with a global prevalence of 1 in 100[1], primarily affecting the small intestine, often accompanied by a variety of multiorgan clinical symptoms. The immune system's abnormal response in celiac disease is triggered by the consumption of gluten in genetically susceptible individuals, leading to the production of autoantibodies and small bowel damage. Celiac disease is a chronic autoimmune disorder with a global prevalence of 1 in 100 [1],...
PR Newswire
03/09/2024

Trading in GN Store Nord shares by board members, executives and associated…

GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them. Details of the person discharging managerial responsibilities/person closely associatedNamePeter KarlstromerReason for the notificationPosition/statusChief Executive OfficerInitial...
Nasdaq GlobeNewswire
03/09/2024

ThermTec Launches New Wild-D Series, Taking Hunting Exploration to the Next…

Key Features of the Wild-D Series: Key Features of the Wild-D Series: "The combination of dual field of view and precise image quality not only meets market demands but ensures ThermTec's consistent quality standards. We are excited to launch the Wild-D series, which offers versatility and durability to keep pace with the times. We look forward to seeing this product provide an unprecedented experience for users across various fields," said Taurus He, Director of Sales and Marketing...
PR Newswire
03/09/2024

SKF announces changes to Group Management

"I'm happy to welcome Susanne back to SKF and look forward to working together. She will play a key role in our exciting journey forward," says Rickard Gustafson, President and CEO. "I'm happy to welcome Susanne back to SKF and look forward to working together. She will play a key role in our exciting journey forward," saysRickard Gustafson, President and CEO. Susanne has led many financial and strategic change management initiatives and will provide valuable contribution to…
PR Newswire
03/09/2024

IFA 2024: Premium brand AEG unveils best-ever Kitchen Range with AI-assisted…

AEG's most significant full kitchen launch to date AEG's most significant full kitchen launch to date The new AEG Kitchen Range includes solutions in every product category, including ovens, hobs, hoods, refrigeration and dishwashers. Designed for consumers who want to take their cooking skills further, the new range is packed with smart technology including AI TasteAssist, a new cutting-edge function that has been developed to help consumers make the most of their oven when trying new...
PR Newswire
03/09/2024

THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the…

The EU MDR 2017/745 is a rigorous regulatory certification program for medical devices intended to support innovation while maintaining safety. The process for THERAKOS to achieve this new CE certificate involved a quality management system audit of the Dublin site, a technical review, a microbiological review, and a thorough clinical assessment. The EU MDR 2017/745 is a rigorous regulatory certification program for medical devices intended to support innovation while maintaining safety...
PR Newswire
03/09/2024

THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the…

The EU MDR 2017/745 is a rigorous regulatory certification program for medical devices intended to support innovation while maintaining safety. The process for THERAKOS to achieve this new CE certificate involved a quality management system audit of the Dublin site, a technical review, a microbiological review, and a thorough clinical assessment. The EU MDR 2017/745 is a rigorous regulatory certification program for medical devices intended to support innovation while maintaining safety...
PR Newswire
03/09/2024

Orexo to participate in Pareto Securities´ 15th Annual Healthcare Conference…

For more information, please contact:Orexo AB (publ.)Lena Wange, IR & Communications Director+46 18 780 88 00ir@orexo.com For more information, please contact: Orexo AB (publ.) Lena Wange, IR & Communications Director +46 18 780 88 00ir@orexo.com About Orexo Orexo is a Swedish pharmaceutical company with nearly 30 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo...
PR Newswire
03/09/2024

AMSilk joins World Economic Forum's Global Innovators Community

Ulrich Scherbel, Chief Executive Officer of AMSilk, commented: "Being invited to join the World Economic Forum's Global Innovators Community stands as testament to our status as a global leader in advanced biomaterials. We look forward to continuing to demonstrate our commitment to innovation, industrial biotechnology and the advancement of the bioeconomy by contributing to the Forum's important work and initiatives." Ulrich Scherbel, Chief Executive Officer of AMSilk, commented…
PR Newswire
03/09/2024

QL Biopharm Announces Abstract on Novel Ultra Long-acting GLP-1RA to be…

BEIJING, Sept. 3, 2024 /PRNewswire/ -- Beijing QL Biopharmaceutical Co., Ltd. ("QL Biopharm"), a clinical stage biopharmaceutical company developing innovative biologic drugs for the treatment of metabolic diseases, today announces that an abstract on its lead drug candidate ZT002 will be presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2024, Madrid, Spain on Thursday 12 September 2024. BEIJING,Sept. 3, 2024/PRNewswire/ -- Beijing QL…
PR Newswire
03/09/2024

Aidoc Launches Seven New AI Solutions to Tackle Europe's Healthcare Challenges

The new algorithms, which have now all achieved medical device CE-marking under MDR, include four solutions for notifying and triaging urgent pathologies: vessel occlusion, aortic dissection, vertebral compression fractures and malpositioned endotracheal tube. Alongside these, there are three new quantification solutions that provide standardised quantitative assessments of cardiovascular and neurological conditions: midline shift, coronary artery calcification and abdominal aortic measurement…
PR Newswire
03/09/2024

Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer

Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer The appointment will accelerate the Company's next phase of growth, advancing its next generation Targeted Glue™ protein degraders into the clinic and building a robust pipeline Appointment follows achievement of three key milestones for Amphista in 2024 which demonstrated: in vivo efficacy, ability to target and degrade proteins in the CNS and novel mechanism of action for the degradation of proteins ...
Nasdaq GlobeNewswire
03/09/2024
Altri  Comunicati